Earnings are filtering in, and companies are seeing a tale of two very different consumers. The group raising concerns about their customer base, and the names not seeing any slowdown. Plus Novo an">

CNBC's "Fast Money"

Different Reads On The Consumer… And Pharma’s Obesity Drug Price Negotiations 11/5/25

Key Takeaways

Deep Dive

More from CNBC's "Fast Money"

Explore all episode briefs from this podcast

View All Episodes →

Listen smarter with PodBrief

Get AI-powered briefs for all your favorite podcasts, plus a daily feed that keeps you informed.

Download on the App Store